has been cited by the following article(s):
[1]
|
Polymorphism in the TP63 gene imparts a potential risk for leukemia in the North Indian population
|
|
African Health …,
2021 |
|
|
[2]
|
Differences in Toxicological and Pharmacological Responses Mediated by Polymorphic Cytochromes P450 and Related Drug-Metabolizing Enzymes
|
|
Chemical Research in Toxicology,
2016 |
|
|
[3]
|
Data in Brief
|
|
2015 |
|
|
[4]
|
Genotyping of wild-type cytochrome P450 2A6 and whole-gene deletion using human blood samples and a multiplex real-time polymerase chain reaction method with …
|
|
Clinica Chimica Acta,
2015 |
|
|
[5]
|
Genotyping of wild-type cytochrome P450 2A6 and whole-gene deletion using human blood samples and a multiplex real-time polymerase chain reaction method with dual-labeled probes
|
|
Clinica Chimica Acta,
2015 |
|
|
[6]
|
Dataset for genotyping validation of cytochrome P450 2A6 whole-gene deletion (CYP2A6* 4) by real-time polymerase chain reaction platforms
|
|
Data in Brief,
2015 |
|
|
[7]
|
Species, Ethnic, and Individual Differences in Human Drug-Metabolizing Cytochrome P450 P450 Enzymes
|
|
Fifty Years of Cytochrome P450 Research,
2014 |
|
|
[8]
|
Species, ethnic, and individual differences in human drug-metabolizing cytochrome P450 enzymes
|
|
2014 |
|
|
[9]
|
Effects of ADH1C, ALDH2, and CYP2A6 Polymorphisms on Individual Risk of Tobacco-Related Lung Cancer in Male Japanese Smokers
|
|
Journal of Cancer Therapy,
2013 |
|
|
[10]
|
TERT-CLPTM1L polymorphism rs401681 contributes to cancers risk: evidence from a meta-analysis based on 29 publications
|
|
PloS one,
2012 |
|
|
[11]
|
Cytochrome P450 2A6 phenotyping based on dietary caffeine intake in a Japanese population of non-smokers
|
|
Drug metabolism letters,
2012 |
|
|
[1]
|
Differences in Toxicological and Pharmacological Responses Mediated by Polymorphic Cytochromes P450 and Related Drug-Metabolizing Enzymes
Chemical Research in Toxicology,
2017
DOI:10.1021/acs.chemrestox.6b00286
|
|
|
[2]
|
Differences in Toxicological and Pharmacological Responses Mediated by Polymorphic Cytochromes P450 and Related Drug-Metabolizing Enzymes
Chemical Research in Toxicology,
2017
DOI:10.1021/acs.chemrestox.6b00286
|
|
|
[3]
|
Dataset for genotyping validation of cytochrome P450 2A6 whole-gene deletion ( CYP2A6 * 4 ) by real-time polymerase chain reaction platforms
Data in Brief,
2015
DOI:10.1016/j.dib.2015.10.019
|
|
|
[4]
|
Genotyping of wild-type cytochrome P450 2A6 and whole-gene deletion using human blood samples and a multiplex real-time polymerase chain reaction method with dual-labeled probes
Clinica Chimica Acta,
2015
DOI:10.1016/j.cca.2014.12.018
|
|
|
[5]
|
Fifty Years of Cytochrome P450 Research
2014
DOI:10.1007/978-4-431-54992-5_17
|
|
|
[6]
|
Fifty Years of Cytochrome P450 Research
2014
DOI:10.1007/978-4-431-54992-5_17
|
|
|
[7]
|
Effects of ADH1C, ALDH2, and CYP2A6 Polymorphisms on Individual Risk of Tobacco-Related Lung Cancer in Male Japanese Smokers
Journal of Cancer Therapy,
2013
DOI:10.4236/jct.2013.48A005
|
|
|
[8]
|
TERT-CLPTM1L Polymorphism rs401681 Contributes to Cancers Risk: Evidence from a Meta-Analysis Based on 29 Publications
PLoS ONE,
2012
DOI:10.1371/journal.pone.0050650
|
|
|